Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders. | Transl Psychiatry | 2023 | 37344453 | PubTator, text mining | PubMed |
| Role of G-protein coupled receptors in cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37342437 | PubTator, text mining | PubMed |
| Lipid metabolism and rheumatoid arthritis. | Front Immunol | 2023 | 37325667 | PubTator, text mining | PubMed |
| A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies. | J Cancer Res Clin Oncol | 2023 | 37318595 | PubTator, text mining | PubMed |
| Identification and assessment of novel dynamic biomarkers for monitoring non-traumatic osteonecrosis of the femoral head staging. | Clin Transl Med | 2023 | 37313692 | PubTator, text mining | PubMed |
| From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. | Acta Neuropathol | 2023 | 37286732 | PubTator, text mining | PubMed |
| Tuberculosis is associated with sputum metabolome variations, irrespective of patient sex or HIV status: an untargeted GCxGC-TOFMS study. | Metabolomics | 2023 | 37284915 | PubTator, text mining | PubMed |
| Exosome-associated lysophosphatidic acid signaling contributes to cancer pain. | Pain | 2023 | 37278638 | PubTator, text mining | PubMed |
| Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84. | Nat Commun | 2023 | 37277332 | PubTator, text mining | PubMed |
| A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation. | Aging (Albany NY) | 2023 | 37276865 | PubTator, text mining | PubMed |
| Deciphering the single-cell transcriptome network in keloids with intra-lesional injection of triamcinolone acetonide combined with 5-fluorouracil. | Front Immunol | 2023 | 37275903 | PubTator, text mining | PubMed |
| Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence. | J Addict Med | 2023 | 37267176 | PubTator, text mining | PubMed |
| Gintonin, a Panax ginseng-derived LPA receptor ligand, attenuates kainic acid-induced seizures and neuronal cell death in the hippocampus via anti-inflammatory and anti-oxidant activities. | J Ginseng Res | 2023 | 37252272 | PubTator, text mining | PubMed |
| In vivo Drug Screening to Identify Anti-metastatic Drugs in Twist1a-ERT2 Transgenic Zebrafish. | Bio Protoc | 2023 | 37251091 | PubTator, text mining | PubMed |
| The genetic architecture of fornix white matter microstructure and their involvement in neuropsychiatric disorders. | Transl Psychiatry | 2023 | 37236919 | PubTator, text mining | PubMed |
| Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors. | Immunooncol Technol | 2023 | 37234285 | PubTator, text mining | PubMed |
| Inflammatory and interferon gene expression signatures in patients with mitochondrial disease. | J Transl Med | 2023 | 37208779 | PubTator, text mining | PubMed |
| The contribution of lysophosphatidic acid receptors in the response of human lower esophageal sphincter under the electrical field stimulation. | BMC Gastroenterol | 2023 | 37202729 | PubTator, text mining | PubMed |
| The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer. | Int J Mol Sci | 2023 | 37176032 | PubTator, text mining | PubMed |
| Inhibition of lysophosphatidic acid receptor 1 relieves PMN recruitment in CNS via LPA1/TSP1/CXCR2 pathway and alleviates disruption on blood-brain barrier following intracerebral haemorrhage in mice. | Fluids Barriers CNS | 2023 | 37165450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=12